AstraZeneca

start line beginning road path starting point journey
Biotech

ESMO: AstraZeneca posts data on ADC rivals to AbbVie, Pfizer

AstraZeneca has shared an early look at its in-house ADCs, publishing phase 1 data on assets that could compete with molecules from AbbVie and Pfizer.
Nick Paul Taylor Sep 14, 2024 3:00am
lung cancer

AstraZeneca, Daiichi unpack Dato-DXd's overall survival fail

Sep 10, 2024 6:00am
Amazing landscapes of Appenzell with impressive rock formations and beautiful lakes

Boehringer, Bayer advance lung cancer meds toward Enhertu battle

Sep 9, 2024 4:43pm
AZ

AZ outlines AI-enabled TROP2 biomarker strategy for Daiichi ADC

Sep 8, 2024 12:22pm
A doctor with a graphic representation of the lungs

AstraZeneca IL-33 drug fails to improve COPD breathing in ph. 2

Sep 8, 2024 9:45am
A graphic representation of a DNA sequence

Qiagen, AstraZeneca expand DNA test collaboration beyond cancer

Aug 29, 2024 11:30am